Unlike CD4+ and CD8+ T cells observed in melanoma patients, T cells observed in breast tumors showed differential expression of the CD27 cell surface marker, where only half of the CD28+ cells were also positive for cell-surface CD27. This evidence concerns the gene CD4 and breast neoplasm.